reviewTop 1% cited
Cellular and molecular pathobiology of pulmonary arterial hypertension
Journal of the American College of Cardiology · 2004 · Vol. 43(12) · pp. S13–S24
Marc Humbert✉(Université Paris-Sud)Nicholas W. Morrell(University of Cambridge)Stephen L. Archer(University of Alberta)Kurt R. Stenmark(University of Colorado Health)Margaret R. MacLean(University of Glasgow)Iréne Lang(University of Vienna)Brian W. Christman(Vanderbilt University)Ε. Kenneth Weir(Veterans Health Administration)Oliver Eickelberg(Justus-Liebig-Universität Gießen)Norbert F. Voelkel(University of Colorado Health)Marlene Rabinovitch(Stanford University)
Pulmonary Hypertension Research and TreatmentsCardiac Fibrosis and RemodelingVascular Anomalies and TreatmentsMedicineProstacyclinVasoconstrictionPulmonary hypertensionEndothelial dysfunctionNitric oxideHypoxic pulmonary vasoconstrictionEndotheliumInternal medicineVasodilation
MeSH terms
Endothelium, VascularHumansHypertension, PulmonaryMolecular BiologyMuscle, Smooth, VascularPulmonary ArteryVascular ResistanceVasoconstriction
Citations
1,552
FWCI
59.45
field-weighted impact
References
67
Percentile
100%
vs. same field & year
Citations per year
Cited by
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
European Heart Journal · 2009 · 3,846 citations
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
Journal of the American College of Cardiology · 2009 · 2,349 citations
Guidelines for the diagnosis and treatment of pulmonary hypertension
European Respiratory Journal · 2009 · 1,291 citations
References
Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis
The Journal of Pathology · 2001 · 491 citations
Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor–II Gene
The American Journal of Human Genetics · 2000 · 1,201 citations
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
The FASEB Journal · 2001 · 801 citations
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Cell · 2003 · 5,831 citations
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family
Journal of Medical Genetics · 2000 · 732 citations
Controlling TGF-β signaling
Genes & Development · 2000 · 1,563 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.